David van de Vijver
David van de Vijver
Department of virology, Erasmus Medical Centre, Erasmus University, Rotterdam, The Netherlands
Geverifieerd e-mailadres voor erasmusmc.nl - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update
DE Bennett, RJ Camacho, D Otelea, DR Kuritzkes, H Fleury, M Kiuchi, ...
PloS one 4 (3), e4724, 2009
9402009
Pathogenesis and transmission of swine-origin 2009 A (H1N1) influenza virus in ferrets
VJ Munster, E de Wit, JMA van den Brand, S Herfst, EJA Schrauwen, ...
Science 325 (5939), 481-483, 2009
7152009
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management
AMJ Wensing, DA Van De Vijver, G Angarano, B Åsjö, C Balotta, E Boeri, ...
The Journal of infectious diseases 192 (6), 958-966, 2005
5432005
An automated genotyping system for analysis of HIV-1 and other microbial sequences
T De Oliveira, K Deforche, S Cassol, M Salminen, D Paraskevis, ...
Bioinformatics 21 (19), 3797-3800, 2005
5212005
Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures
MK Hayden, MJM Bonten, DW Blom, EA Lyle, DAMC van de Vijver, ...
Clinical Infectious Diseases 42 (11), 1552-1560, 2006
4522006
Transmission of drug-resistant HIV-1 is stabilizing in Europe
J Vercauteren, AMJ Wensing, DAMC van de Vijver, J Albert, C Balotta, ...
The Journal of infectious diseases 200 (10), 1503-1508, 2009
2772009
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis
SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ...
PLoS Med 12 (4), e1001810, 2015
2192015
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical …
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
1962014
Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world
D Frentz, CA Boucher, DA Van De Vijver
AIDs Rev 14 (1), 17-27, 2012
1842012
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study
H Razavi, S Robbins, S Zeuzem, F Negro, M Buti, AS Duberg, ...
The Lancet gastroenterology and hepatology, 2017
1632017
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
AB Abecasis, AMJ Wensing, D Paraskevis, J Vercauteren, K Theys, ...
Retrovirology 10 (1), 7, 2013
1532013
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
D Paraskevis, O Pybus, G Magiorkinis, A Hatzakis, AMJ Wensing, ...
Retrovirology 6 (1), 1-11, 2009
1412009
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes
DA van de Vijver, AMJ Wensing, G Angarano, B Åsjö, C Balotta, E Boeri, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 41 (3), 352-360, 2006
1312006
Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe
LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ...
Clinical infectious diseases 62 (5), 655-663, 2016
1292016
Sustainable HIV treatment in Africa through viral-load-informed differentiated care
A Phillips, A Shroufi, L Vojnov, J Cohn, T Roberts, T Ellman, K Bonner, ...
Nature 528 (7580), S68-S76, 2015
1192015
Stochastic simulation of HIV population dynamics through complex network modelling
PMA Sloot, SV Ivanov, AV Boukhanovsky, DAMC van de Vijver, ...
International Journal of Computer Mathematics 85 (8), 1175-1187, 2008
982008
Declining hepatitis C virus (HCV) incidence in Dutch human immunodeficiency virus-positive men who have sex with men after unrestricted access to HCV therapy
A Boerekamps, GE van den Berk, FN Lauw, EM Leyten, ME van Kasteren, ...
Clinical Infectious Diseases 66 (9), 1360-1365, 2018
97*2018
Epidemiology of restless legs syndrome as diagnosed in UK primary care
DAMC van de Vijver, T Walley, H Petri
Sleep medicine 5 (5), 435-440, 2004
822004
Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study
BE Nichols, CAB Boucher, M van der Valk, BJA Rijnders, ...
The Lancet Infectious Diseases 16 (12), 1423-1429, 2016
802016
Profiling of humoral immune responses to influenza viruses by using protein microarray
M Koopmans, E de Bruin, GJ Godeke, I Friesema, R Van Gageldonk, ...
Clinical Microbiology and Infection 18 (8), 797-807, 2012
802012
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20